The addition of more co-stimulatory signals, other adjuvants, or signaling domains to CARs by genetic additions has become an increasing trend in the field ( 51 – 53 ).
← all excerpts
Lipid-Mediated Insertion of Toll-Like Receptor (TLR) Ligands for Facile Immune Cell Engineering.
1
—
—